Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001344755 | SCV001538832 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002357188 | SCV002622867 | uncertain significance | Cardiovascular phenotype | 2022-08-16 | criteria provided, single submitter | clinical testing | The p.T1289M variant (also known as c.3866C>T), located in coding exon 22 of the FLNC gene, results from a C to T substitution at nucleotide position 3866. The threonine at codon 1289 is replaced by methionine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |